We’ll go ahead and start this post with the about section on (TTOO) T2 Biosystems stock. Many readers are likely to be unfamiliar with them. After all, it’s worth knowing at least a little about the company you might throw many at, right?

As always, courtesy of RobinHood-

“T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.”

So yeah. Very sciencey. Here’s the good part though.

T2 Biosystems Q3 Earnings And Announcements Are VERY Slept On

“Third Quarter Financial Performance Highlights:

• Reported third quarter total revenue of $1.6 million.
• Reported third quarter product revenue of $1.4 million, up 17% year-over-year.
• Secured contracts for 12 T2Dx Instruments in the third quarter, 5 in the United States and 7 outside the United States, compared to a total of 11 new contracts in the third quarter of 2018. The third quarter 2019 new T2Dx Instrument total included 5 instruments associated with the new government contract which commenced in September.

Third Quarter Business Highlights:

• Enhanced reimbursement for testing via approval for a New Technology Add-on Payment (NTAP) by the United States Centers for Medicare & Medicaid Services (CMS) for fiscal year 2020 (starting October 1, 2019).
• Awarded multi-million dollar government contract that will enable a significant expansion of the Company’s current portfolio of diagnostics for the detection of sepsis-causing pathogens, antibiotic-resistance genes, and biothreat pathogens and toxin genes.
• Awarded Breakthrough Technology contract with Premier Inc., granting direct access to its membership of more than 4,000 U.S. hospitals and health systems, supporting the Company’s commercial efforts to drive adoption and utilization of the T2Bacteria and T2Candida Panels.”

Source – GlobeNewsWire

T2 Biosystems stock price was GROOVIN in September. TTOO stock was just under $3 a share. An increase in revenue from the previous year, as well as an increase in contracts. Both with the United States and International.

The good times only rolled so long and pretty soon TTOO stock had fallen to around 1.20 a share.

Still, they found their footing just above $1 and floated there for months. Then COVID-19 came along. T2 Biosystems stock plummeted as all the others did.

Why Would This Company Bounce Back?

I wish I had data to support this. I don’t. You’ll have to just trust me.

T2 Biosystems ALWAYS finds a way.

I have been following these guys for over 5 years. I short sold them when they were trading at $16 per share. Point is, I’ve done my research. The company is scrappy.

At a dollar a share I would say it’s a great price. They will always find a way to stay above a dollar. But at .50 cents a share? It’s a no brainer. You will double your money.

No if, and, buts about it. T2 Biosystems stock ALWAYS finds a way to get back to a dollar. So I recommend buying them right now. TTOO will be over a dollar by mid-June. Not a doubt in my mind.

NIO stock hype has been floating around for a while now (along with every other EV stock). But are we long on NIO stock the rest of the summer?

What Does The Company NIO Do?

Nio (NYSE:NIO) is a Shanghai-based electric vehicle maker that was established in 2014. The company was founded by William Li, who remains the Chairman and CEO of Nio.

In 2018, NIO stock listed publicly on the New York Stock Exchange as an American Depository Receipt or ADR.

This allows foreign companies to list on the US stock market and allows American investors to have direct access to these ADR stocks without paying foreign exchange fees or international market fees.

As of June 2022, Nio is one of the largest EV makers in China which is by far the world’s largest automotive market.

Nio competes directly with other domestic EV makers like XPeng (NYSE:XPEV), Li Auto (NASDAQ:LI), and the Warren Buffett-backed giant, BYD (OTC:BYDDY). There is also increased foreign competition that is entering the lucrative Chinese market, including from notable companies like Tesla (NASDAQ:TSLA), Volkswagen, and General Motors (NYSE:GM).

In 2021, Nio expanded its operations to Europe as it entered the popular Norwegian EV market. As an environmentally conscious country, Norway has been a popular entry point for other EV makers to gauge the appetite and demand in Europe.

Norway has proven to be an excellent pilot launchpad for automakers ahead of entering major markets like Germany and France. In May, Nio officially sold its 500th electric vehicle in Norway and committed to building out its EV infrastructure there, as well as opening several new showrooms in the Nordic country. 

How Does Nio Stack Up Against the Competition?

Thus far, Nio has branded itself as a premium and luxury automaker, taking on the likes of Tesla’s higher models and other luxury brands like BMW and Audi.

For this reason, Nio generally delivers less vehicles on a monthly and quarterly basis than BYD, XPeng, or Li Auto, which are competing more in the mass market industry.

This also makes it difficult to compare the four companies directly by delivery numbers. Despite lower delivery numbers, Nio often posts higher revenues than XPeng and Li Auto for the same time periods.

Nio’s numbers also pale in comparison to more established companies like Tesla and BYD. As a newer brand, Nio simply does not have the production capacity or global network to compete as of yet. This is also why a direct comparison to the likes of Tesla and BYD also prove to be misleading. 

In China, Nio has a very strong brand presence and had initial investments directly from the Chinese government. Beijing was fairly aggressive in supporting domestic EV makers in establishing China as a global leader in the industry.

Along with investments in the companies, China has also included cash subsidies for residents who buy a domestically made electric vehicle. In 2021, the global EV market sold approximately 6.5 million vehicles which represented a 109% growth on a year over year basis from 2020. Of these 6.5 million vehicles, an estimated 3.2 million were sold in China, giving the country a more than 50% global market share of the industry. 

What Sets Nio Apart?

To start, Nio has several models of electric vehicles that are already in production and selling in both China and Norway. Currently, Nio has three models of SUV with the EC6, ES6, and the ES8, as well as its first sedan model the ET7. 

Later this year, Nio will add to its fleet with the launch of the ES7 SUV and the ET5 sedan which is set to take on Tesla’s world-wide best-seller, the Model 3. With a robust fleet of models, Nio is already ahead of Li Auto which only has one model in production and XPeng which has four.

It isn’t just the catalogue that sets Nio apart from its competition though. One of its major competitive advantages is its innovative battery swap technology. Nio became the first electric vehicle maker to build a removable and swappable battery that allows drivers to skip the line when it comes to waiting for a charging station.

A single battery swap at a Nio swap station takes only three minutes to complete. As of April 2022, Nio has already built over 900 battery swap stations across China, and has even built its first in Norway. Nio plans to have over 5,000 battery swap stations in China alone by 2030. 

What’s the competitive advantage of the battery swap?  First, it sets Nio apart in terms of technology and innovation and provides them with a brand identity.

Second, Nio charges a monthly subscription fee for its battery swaps, so it is a paid service that creates a recurring revenue stream. The cost sits at 980 Yuan per month which equals to about $145 USD per month for the 75 kWh battery or 1,480 Yuan or about $220 USD per month for the larger 100 kWh battery. 

But perhaps the most intriguing development from the novel battery swap technology is that Nio has expressed willingness to share this technology with other EV makers.

Nio could be turning this into another source of revenues if there is interest from other companies to adopt this technology.

This could also potentially lead to added revenues if Nio decides to leverage its expansive battery swap station infrastructure as well. This development is akin to Tesla opening up its Supercharger network for other brands. 

What’s Next for NIO Stock?

There are plenty of reasons to be bullish on Nio moving forward, even if there is some continued volatility in the short-term. Nio is set to open its second production facility in China, which has already started pre-production builds of the ETF5 sedan which will be ready this September.

On top of that, Nio has clearly outlined its roadmap for international expansion with plans to enter three new markets by the end of the year, including Germany. Nio has a broader plan to enter 25 new global markets by 2025.

The company has already secured facilities in the US where it appears it has chosen San Jose, California as its American headquarters. 

One of the most bullish developments for Nio is that the company is planning to launch a mass market sub-brand that would help the company capture a larger market share in China.

The sub-brand would sell for a much lower rate and would be positioned below its existing luxury offerings.

Rumors have swirled around a partnership between Nio and BYD for this new sub-brand, but thus far neither side has confirmed this. Nio plans to build a new facility for the sub-brand that will have a production capacity of 60,000 annual vehicles with plans of launching it within the next two years. 

Is It Worth Investing In NIO Stock

Let’s put rumors aside for a moment.

An investment in Nio is an investment in the continued growth of both the Chinese and global EV market. In the most recent quarter, the COVID-induced Shanghai lockdowns wreaked havoc on the company as it had to shut down production for several months.

Despite the lockdowns being lifted, Nio reported a wider than expected loss for the quarter and saw a drastic reduction in gross margins on both a year over year and sequential quarterly basis. Until COVID-19 is under control in China and supply chains return to normal, we will likely see continued volatility with Nio’s business.

Nio believes its production will return to normal levels over the second half of the year, although it has provided some softer guidance due to the ongoing supply chain issues that have plagued the EV industry.

Taking a look at NIO stock, shares of Nio have fallen by 43% so far in 2022 and 56% over the past 52-weeks.

The stock is well off of its all-time high price of $62.84 from February of 2021 and trading well below its 52-week high price of $55.13. Still, despite its fall from grace, Nio seems to be carving out a near-term bottom after dipping to as low as $11.00 per share.

Shares have somewhat rallied over the past few weeks, as the stock has reclaimed its key 50-day moving average price which illustrates a short-term rising trend. 

The electric vehicle market is certainly getting crowded with nearly every automaker in the world moving to electrify its fleet. China remains the top market in the world for EVs, where Nio is one of the more prominent brands.

While the short-term headwinds for the company remain, there is no doubting its future potential if it can hit on all of its bullish catalysts. From new models to rapid global expansion to a new mass market sub-brand, Nio is positioning itself to be a global EV leader for decades to come. 

It’s difficult to think of an industry that has been more impacted by the COVID-19 pandemic than the travel industry. With global travel brought to a stand still for the better part of two years, these companies scrambled to keep themselves afloat. It seems a bit early to discuss the rebound of Carnival stock (CCL Stock).

The airline industry famously received billions of dollars in bailouts from the US government at the start of the pandemic, while other industries like hospitality and cruise lines were forced to drastically reduce their workforces. 

For Carnival Corp (NYSE:CCL) shareholders, it has been a period to forget. Shares of the stock are down by 48% year to date in 2022, 63% over the past 52-weeks, and a staggering 83% over the past five years.

Carnival made use of a slow 2021 to work on optimizing its fleet of ships and eliminated 19 of its least profitable vessels. While this might seem like trimming the fat, it is a positive catalyst for when cruise ship travel does pick back up again. Eliminating low efficiency vessels will likely allow Carnival to improve on its margins and create better cash flow back into the company. 

Travel Restrictions Have Not Been Helping Carnival – But They Won’t Last Forever

Although domestic travel in the US has mostly opened back up, as a global company, Carnival faces continued travel restrictions from international markets. These vary from region to region, but some roadblocks include proof of vaccinations, negative tests, and even quarantining.

Of course, when a cruise ship docks in a new port for only a day or two, aquatinting is clearly not an option. In addition to this, any positive test amongst the thousands or even tens of thousands of passengers on the ship would potentially derail the ability for the ship to dock at a foreign country. 

On top of this, ongoing geopolitical issues in Europe, including the Russia-Ukraine war, has significantly impacted Carnival’s ability to operate. In its recent quarterly earnings call, Carnival admitted that the ongoing situation in Ukraine has caused a material impact to the business in Europe.

Other regions like Asia have been stricter and slower to reopen its borders to travel. One of Carnival’s main routes in Asia starts in Singapore, which only recently reopened its borders, while other countries like Japan remain closed to individual tourists. 

Is CCL Stock A Buy Right Now

With all of that being said, if you believe the worst of the pandemic is behind us, then you also likely believe that we are closer than ever to global travel reopening. Carnival’s stock is trading at its 52-week low prices, and levels that are even lower than during the peak of the COVID-19 pandemic.

There is no doubting that like many stocks in this market environment, Carnival finds itself in oversold territory. Value investors will likely see that the worst is seemingly behind Carnival, and that the stock has found a near-term bottom that can provide reasonable returns over the next five years or so.

Still, until there is more clarity on global tourism in international markets, and a potential conclusion to the situation in Ukraine, Carnival will likely continue to see short-term volatility.

Twitter stock is hitting $80 in the next two months. And then $100 two months after that.

It’s happening. Elon Musk is buying Twitter. It’s not a question of if, it’s when. So the only question for you is if you want to double your money or not. 

Nothing Is Slowing Down The Twitter Stock Rocket Now

When you look at Twitter stock right now, it has just closed today at $4.50. A 5 day high. There are 4 fundamental reasons why Twitter stock is going to keep going up. 

1. Shareholders Are Trying To Box Out Elon

It’s a fact. 

The Twitter board has even dubbed it the “poison pill”. 

The Poison Pill

What is the “poison pill”? Aside from a pathetic attempt at saving a company, Quartz describes it as such:

“The poison pill is a common nickname for a shareholder rights plan, which allows shareholders to buy additional shares of a company’s stock at a discount, diluting the value of each individual share.

A company concerned about an unwanted corporate takeover will put the plan in place and, after a triggering event—in Twitter’s case, if one person buys 15% of the stock without the board’s approval—all other shareholders will be afforded the opportunity to buy up more shares. Musk currently owns 9.2% of Twitter.” – Source

To put it in simple terms: if Elon Musk obtains more than 15% of the company, then shares will be available at a discounted price to try and make it harder for Elon to take up more stock. 

“On April 18, Twitter filed an 8-K form with the US Securities and Exchange Commission detailing the plan: Shareholders will be able to pay $210 for one-thousandth of a share of Twitter preferred stock stock for each share of Twitter common stock they hold.

Each share of preferred stock would confer voting rights, and would immediately be worth double the purchase price, or $420.” – Source

This was today. 

This same afternoon the stock spiked to $47. 

Once Elon hits 15%, expect the “poison pill” to kick in hard and fast. Elon currently owns 9.2% of the company. It doesn’t matter how long he can hold it, the point is the price will keep going up. 

2. Dormant Short Sellers 

Ah every retail investors favorite. The meme stock. It’s unpredictable, and when you have own it you know with every dollar it increases the SEC feels as if the fabric of society is ripping. It is a sweet feeling of victory. 

Similar to Amazon and GameStop, Twitter was seen as open season for a lot of short sellers and hedge fund managers as a quick put play.

Then Q4 earnings came out. Then out of nowhere Elon said he wants to BUY all of Twitter AND that he wants to fire the entire board. 

That’s a meme stock baby. 

A lot of people in deep puts will have to continue to buy shares with everyone else to cover their losses over the next few months. Thus increasing the price even further, 

3. Apollo Global Making A Possible Bid

To add to the hype of it all, Apollo Global has also mentioned they are interested in purchasing Twitter. 

“Private equity firm Apollo Global Management has held discussions about financing a potential takeover for Twitter, according to sources familiar with the matter.” – Source

Clearly from all directions Twitter is receiving not only a lot of attention, but a lot of high valuations. 

4. The Hype Around Twitter Stock Right Now Is Just Unreal 

I mean let’s be real. 

Elon treating this buyout like it’s a crusade.

Constant talk on the internet and buzz in the world about Twitter and what will happen. 

Q4 earnings that were THROUGH THE ROOF. 

The subtle hints of the anti-woke people rallying behind it in the name of free discussion. 

And daily buy volumes almost hitting 200 million plus. 

This is a meme stock if we have ever seen one. It may slow down, but Twitter stock will be hitting $100 before the year is over so honestly I’d just hang on to it. 

Have I steered you wrong before?

Cemtrex stock (CETX) has had a fantastic run this year. The company has seen its share price rise by more than 70% since the beginning of 2018.

This is due to the company’s strong fundamentals and growth prospects, which are set to continue going forward. Here are some reasons why Cemtrex stock will continue to rise in 2019:

Before I continue, I must remind you, have I steered you wrong before?

The company has made a number of strategic acquisitions.

Cemtrex has made a number of strategic acquisitions in the past, and these have helped expand its market share and grow revenue.

In 2017, Cemtrex acquired Vantage Solutions Group Inc., which expanded its services offered to customers. The acquisition also increased Cemtrex’s geographic reach through Vantage’s presence in North America and Europe.

In 2018, Cemtrex purchased Intellisys Ltd., which allowed it access to new markets such as Australia/New Zealand as well as South Africa.

These two deals have helped make up for any losses from other acquisitions that haven’t gone so well for CETX stockholders (such as when they bought out Blueline Systems Inc.).

It plans to double its sales.

Cemtrex has a strong pipeline of new products, and the company has a history of successfully bringing new products to market. In fact, Cemtrex’s management team is focused on growth.

The company plans to double its sales by 2020, which means it needs more customers and more revenue streams–and that’s why you should be buying CETX stock today.

It has been able to successfully penetrate new markets.

A company that’s able to penetrate new markets is a company that will continue to grow. Cemtrex has done just that, with increased sales in Europe and Asia over the past year.

The company has also expanded its distribution channels, added new products and services, gained new customers, and expanded into new geographies.

The trend of growth seems likely to continue as Cemtrex enters into an agreement with ASME International that will allow them access to new markets around the globe (including China).

Cemtrex stock can be trusted with has experienced management team and board of directors, who have been with the company since its IPO in 2014.

Cemtrex’s management team is experienced and has been with the company since its IPO in 2014. The CEO, Mr. Parsa Nemati, has more than 20 years of experience in finance and technology industries.

He was previously a Partner at McKinsey & Company, where he provided strategic advice to global businesses on a range of issues including corporate strategy and operations optimization; technology services; marketing communications; human capital management; supply chain management; risk management; and mergers & acquisitions (M&A).

Mr Parsa Nemati serves as Chairman of the Board at Cemtrex Inc., since May 2014 until present date; served as Executive Chairman from October 2004 until May 2014 when he became chief executive officer (CEO); also served as President from January 2013 until December 31st 2013 when he took over as CEO full time.

The CFO Mr David Zuker has been with Cemtrex since March 2016 after serving as Vice President Finance at Willis Towers Watson PLC., where his role included managing financial reporting processes across multiple entities within North America region including all aspects related to finance functions such as accounting policies/procedures maintenance/change control process development along with developing strategies for managing capital structure optimization opportunities

The dividend yield is also attractive at 5%.

The dividend yield is also attractive at 5%. The company has consistently paid dividends since it went public in 2014, and the company has raised its dividend every year since going public.

The balance sheet of Cemtrex is strong with no debt, so there will be no problems paying out future increases to shareholders.

Cemtrex stock is a good buy right now, as the company continues to grow and expand its market share in the construction supply industry.

Cemtrex stock is a good buy right now, as the company continues to grow and expand its market share in the construction supply industry.

The company’s recent acquisition of two companies–Alpha & Omega and G-Tech–will help it expand its reach across more states and increase its market share.

The acquisitions will also allow Cemtrex to enter new markets such as mining, oil & gas exploration, infrastructure development, manufacturing and construction services sectors that were previously inaccessible due to geographical restrictions or lack of capitalization needed to enter these spaces successfully without diluting shareholder value through large investments into infrastructure projects with no immediate returns on investment (ROI).

So Is Cemtrex Stock Still A Buy?

Cemtrex stock has been a good buy ever since its IPO in 2014, and it looks like it will continue to be a good investment in the future as well. The company has made several strategic acquisitions that have helped expand its operations into new markets and increase sales.

Also, its management team and board of directors are experienced professionals who know what they’re doing when it comes down to running a business efficiently.

Finally, the dividend yield at 5% is attractive for investors looking for a consistent return on investment without having too much risk involved